1887

Abstract

The protective immune response against porcine circovirus 2 (PCV2) infection in mice was characterized using flow cytometric analysis (FCM), assays of antibody (of different IgG isotypes) and viraemia, and histopathological examination. An open reading frame 2 plasmid (pORF2) and the capsid protein (Cap) of PCV2 were used as DNA and subunit vaccines, respectively. In FCM analysis, although pORF2 and Cap alone showed comparable efficacy in eliciting lymphoproliferative responses and Cap-specific CD4 T cells, pORF2 was superior to the Cap protein in triggering CD8 T cells. A virus neutralization assay showed that pORF2 evoked stronger recall virus-neutralizing (VN) antibody responses than the Cap protein on PCV2 challenge. Correspondingly, VN antibody kinetics coincided with those of Cap-specific IgG2a, but not with the kinetics of IgG and IgG1. Following virus challenge, real-time PCR and histopathological analysis confirmed that only low viral DNA loads and mild microscopic lesions appeared in pORF2-immunized mice. These findings indicate that CD8 T cells and VN antibody responses correlating mainly with Cap-specific IgG2a play crucial roles in protecting against PCV2 infection, and that the protective immunity induced by the pORF2 plasmid is superior to that induced by the PCV2 Cap protein.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.2008/000125-0
2008-08-01
2020-10-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/89/8/1857.html?itemId=/content/journal/jgv/10.1099/vir.0.2008/000125-0&mimeType=html&fmt=ahah

References

  1. Abbas A. K., Murphy K. M., Sher A. 1996; Functional diversity of helper T lymphocytes. Nature 383:787–793 [CrossRef]
    [Google Scholar]
  2. Allan G. M., Ellis J. A. 2000; Porcine circoviruses: a review. J Vet Diagn Invest 12:3–14 [CrossRef]
    [Google Scholar]
  3. Allan G., Meehan B., Todd D., Kennedy S., McNeilly F., Ellis J., Clark E. G., Harding J., Espuna E. other authors 1998a; Novel porcine circoviruses from pigs with wasting disease syndromes. Vet Rec 142:467–468
    [Google Scholar]
  4. Allan G. M., McNeilly F., Kennedy S., Daft B., Clarke E. G., Ellis J. A., Haines D. M., Meehan B. M., Adair B. M. 1998b; Isolation of porcine circovirus-like viruses from pigs with a wasting disease in the USA and Europe. J Vet Diagn Invest 10:3–10 [CrossRef]
    [Google Scholar]
  5. Blanchard P., Mahe D., Cariolet R., Keranflec'h A., Baudouard M. A., Cordioli P., Albina E., Jestin A. 2003; Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine 21:4565–4575 [CrossRef]
    [Google Scholar]
  6. Carasova P., Celer V., Takacova K., Trundova M., Molinkova D., Lobova D., Smola J. 2007; The levels of PCV2 specific antibodies and viremia in pigs. Res Vet Sci 83:274–278 [CrossRef]
    [Google Scholar]
  7. Chianini F., Majo N., Segales J., Dominguez J., Domingo M. 2003; Immunohistochemical characterisation of PCV2 associate lesions in lymphoid and non-lymphoid tissues of pigs with natural postweaning multisystemic wasting syndrome (PMWS). Vet Immunol Immunopathol 94:63–75 [CrossRef]
    [Google Scholar]
  8. Clark E. G. 1997; Post-weaning multisystemic wasting syndrome. Proc Am Assoc Swine Pract 28:499–501
    [Google Scholar]
  9. Del Prete G. 1998; The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int Rev Immunol 16:427–455 [CrossRef]
    [Google Scholar]
  10. Doolan D. L., Sedegah M., Hedstrom R. C., Hobart P., Charoenvit Y., Hoffman S. L. 1996; Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. J Exp Med 183:1739–1746 [CrossRef]
    [Google Scholar]
  11. Ellis J., Hassard L., Clark E., Harding J., Allan G., Willson P., Strokappe J., Martin K., McNeilly F. other authors 1998; Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome. Can Vet J 39:44–51
    [Google Scholar]
  12. Fan H., Xiao S., Tong T., Wang S., Xie L., Jiang Y., Chen H., Fang L. 2008; Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments. Mol Immunol 45:653–660 [CrossRef]
    [Google Scholar]
  13. Fenaux M., Halbur P. G., Haqshenas G., Royer R., Thomas P., Nawagitgul P., Gill M., Toth T. E., Meng X. J. 2002; Cloned genomic DNA of type 2 porcine circovirus is infectious when injected directly into the liver and lymph nodes of pigs: characterization of clinical disease, virus distribution, and pathologic lesions. J Virol 76:541–551 [CrossRef]
    [Google Scholar]
  14. Fenaux M., Opriessnig T., Halbur P. G., Meng X. J. 2003; Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs. J Virol 77:11232–11243 [CrossRef]
    [Google Scholar]
  15. Fenaux M., Opriessnig T., Halbur P. G., Elvinger F., Meng X. J. 2004; A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. J Virol 78:6297–6303 [CrossRef]
    [Google Scholar]
  16. Gilpin D. F., McCullough K., Meehan B. M., McNeilly F., McNair I., Stevenson L. S., Foster J. C., Ellis J. A., Krakowka S. other authors 2003; In vitro studies on the infection and replication of porcine circovirus type 2 in cells of the porcine immune system. Vet Immunol Immunopathol 94:149–161 [CrossRef]
    [Google Scholar]
  17. Hamel A. L., Lin L. L., Nayar G. P. 1998; Nucleotide sequence of porcine circovirus associated with postweaning multisystemic wasting syndrome in pigs. J Virol 72:5262–5267
    [Google Scholar]
  18. Hasslung F. C., Berg M., Allan G. M., Meehan B. M., McNeilly F., Fossum C. 2003; Identification of a sequence from the genome of porcine circovirus type 2 with an inhibitory effect on IFN- α production by porcine PBMCs. J Gen Virol 84:2937–2945 [CrossRef]
    [Google Scholar]
  19. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H. other authors 2000; A Toll-like receptor recognizes bacterial DNA. Nature 408:740–745 [CrossRef]
    [Google Scholar]
  20. Hirai T., Nunoya T., Ihara T., Saitoh T., Shibuya K., Nakamura K. 2006; Infectivity of porcine circovirus 1 and circovirus 2 in primary porcine hepatocyte and kidney cell cultures. J Vet Med Sci 68:179–182 [CrossRef]
    [Google Scholar]
  21. Ju C., Fan H., Tan Y., Liu Z., Xi X., Cao S., Wu B., Chen H. 2005; Immunogenicity of a recombinant pseudorabies virus expressing ORF1–ORF2 fusion protein of porcine circovirus type 2. Vet Microbiol 109:179–190 [CrossRef]
    [Google Scholar]
  22. Kamstrup S., Barfoed A. M., Frimann T. H., Ladekjaer-Mikkelsen A. S., Botner A. 2004; Immunisation against PCV2 structural protein by DNA vaccination of mice. Vaccine 22:1358–1361 [CrossRef]
    [Google Scholar]
  23. Kiupel M., Stevenson G. W., Choi J., Latimer K. S., Kanitz C. L., Mittal S. K. 2001; Viral replication and lesions in BALB/c mice experimentally inoculated with porcine circovirus isolated from a pig with postweaning multisystemic wasting disease. Vet Pathol 38:74–82 [CrossRef]
    [Google Scholar]
  24. Liu J., Chen I., Kwang J. 2005; Characterization of a previously unidentified viral protein in porcine circovirus type 2-infected cells and its role in virus-induced apoptosis. J Virol 79:8262–8274 [CrossRef]
    [Google Scholar]
  25. Liu J., Chen I., Du Q., Chua H., Kwang J. 2006; The ORF3 protein of porcine circovirus type 2 is involved in viral pathogenesis in vivo. J Virol 80:5065–5073 [CrossRef]
    [Google Scholar]
  26. Mahe D., Blanchard P., Truong C., Arnauld C., Le Cann P., Cariolet R., Madec F., Albina E., Jestin A. 2000; Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes. J Gen Virol 81:1815–1824
    [Google Scholar]
  27. Mankertz A., Mankertz J., Wolf K., Buhk H. J. 1998; Identification of a protein essential for replication of porcine circovirus. J Gen Virol 79:381–384
    [Google Scholar]
  28. McIntosh K. A., Harding J. C., Ellis J. A., Appleyard G. D. 2006; Detection of Porcine circovirus type 2 viremia and seroconversion in naturally infected pigs in a farrow-to-finish barn. Can J Vet Res 70:58–61
    [Google Scholar]
  29. McKendall R. R., Woo W. 1988; Murine IgG subclass responses to herpes simplex virus type 1 and polypeptides. J Gen Virol 69:847–857 [CrossRef]
    [Google Scholar]
  30. McNeilly F., McNair I., Mackle D. P., Meehan B. M., Kennedy S., Moffett D., Ellis J., Krakowka S., Allan G. M. 2001; Production, characterisation and applications of monoclonal antibodies to porcine circovirus 2. Arch Virol 146:909–922 [CrossRef]
    [Google Scholar]
  31. Meehan B. M., McNeilly F., Todd D., Kennedy S., Jewhurst V. A., Ellis J. A., Hassard L. E., Clark E. G., Haines D. M., Allan G. M. 1998; Characterization of novel circovirus DNAs associated with wasting syndromes in pigs. J Gen Virol 79:2171–2179
    [Google Scholar]
  32. Mosmann T. R., Coffman R. L. 1989a; Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 46:111–147
    [Google Scholar]
  33. Mosmann T. R., Coffman R. L. 1989b; TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145–173 [CrossRef]
    [Google Scholar]
  34. Nawagitgul P., Morozov I., Bolin S. R., Harms P. A., Sorden S. D., Paul P. S. 2000; Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. J Gen Virol 81:2281–2287
    [Google Scholar]
  35. Ogg G. S., Jin X., Bonhoeffer S., Dunbar P. R., Nowak M. A., Monard S., Segal J. P., Cao Y., Rowland-Jones S. L. other authors 1998; Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103–2106 [CrossRef]
    [Google Scholar]
  36. Quintana J., Balasch M., Segales J., Calsamiglia M., Rodriguez-Arrioja G. M., Plana-Duran J., Domingo M. 2002; Experimental inoculation of porcine circoviruses type 1 (PCV1) and type 2 (PCV2) in rabbits and mice. Vet Res 33:229–237 [CrossRef]
    [Google Scholar]
  37. Ruitenberg K. M., Walker C., Love D. N., Wellington J. E., Whalley J. M. 2000; A prime–boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naive and infection-primed mice. Vaccine 18:1367–1373 [CrossRef]
    [Google Scholar]
  38. Sarli G., Mandrioli L., Laurenti M., Sidoli L., Cerati C., Rolla G., Marcato P. S. 2001; Immunohistochemical characterisation of the lymph node reaction in pig post-weaning multisystemic wasting syndrome (PMWS). Vet Immunol Immunopathol 83:53–67 [CrossRef]
    [Google Scholar]
  39. Schmitz J. E., Kuroda M. J., Santra S., Sasseville V. G., Simon M. A., Lifton M. A., Racz P., Tenner-Racz K., Dalesandro M. other authors 1999; Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283:857–860 [CrossRef]
    [Google Scholar]
  40. Seder R. A., Hill A. V. 2000; Vaccines against intracellular infections requiring cellular immunity. Nature 406:793–798 [CrossRef]
    [Google Scholar]
  41. Segales J., Domingo M., Chianini F., Majo N., Dominguez J., Darwich L., Mateu E. 2004; Immunosuppression in postweaning multisystemic wasting syndrome affected pigs. Vet Microbiol 98:151–158 [CrossRef]
    [Google Scholar]
  42. Shang S. B., Li Y. F., Guo J. Q., Wang Z. T., Chen Q. X., Shen H. G., Zhou J. Y. 2008; Development and validation of a recombinant capsid protein-based ELISA for detection of antibody to porcine circovirus type 2. Res Vet Sci 84:150–157 [CrossRef]
    [Google Scholar]
  43. Simmons M., Murphy G. S., Kochel T., Raviprakash K., Hayes C. G. 2001; Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine. Am J Trop Med Hyg 65:420–426
    [Google Scholar]
  44. Sin J. I., Bagarazzi M., Pachuk C., Weiner D. B. 1999; DNA priming–protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model. DNA Cell Biol 18:771–779 [CrossRef]
    [Google Scholar]
  45. Song Y., Jin M., Zhang S., Xu X., Xiao S., Cao S., Chen H. 2007; Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2. Vet Microbiol 119:97–104 [CrossRef]
    [Google Scholar]
  46. Tanghe A., D'Souza S., Rosseels V., Denis O., Ottenhoff T. H., Dalemans W., Wheeler C., Huygen K. 2001; Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect Immun 69:3041–3047 [CrossRef]
    [Google Scholar]
  47. Tischer I., Gelderblom H., Vettermann W., Koch M. A. 1982; A very small porcine virus with circular single-stranded DNA. Nature 295:64–66 [CrossRef]
    [Google Scholar]
  48. Truong C., Mahe D., Blanchard P., Le Dimna M., Madec F., Jestin A., Albina E. 2001; Identification of an immunorelevant ORF2 epitope from porcine circovirus type 2 as a serological marker for experimental and natural infection. Arch Virol 146:1197–1211 [CrossRef]
    [Google Scholar]
  49. Vincent I. E., Carrasco C. P., Herrmann B., Meehan B. M., Allan G. M., Summerfield A., McCullough K. C. 2003; Dendritic cells harbor infectious porcine circovirus type 2 in the absence of apparent cell modulation or replication of the virus. J Virol 77:13288–13300 [CrossRef]
    [Google Scholar]
  50. Wang X., Jiang W., Jiang P., Li Y., Feng Z., Xu J. 2006; Construction and immunogenicity of recombinant adenovirus expressing the capsid protein of porcine circovirus 2 (PCV2) in mice. Vaccine 24:3374–3380 [CrossRef]
    [Google Scholar]
  51. Wang X., Jiang P., Li Y., Jiang W., Dong X. 2007; Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2. Vet Microbiol 121:215–224 [CrossRef]
    [Google Scholar]
  52. Wen L., Guo X., Yang H. 2005; Genotyping of porcine circovirus type 2 from a variety of clinical conditions in China. Vet Microbiol 110:141–146 [CrossRef]
    [Google Scholar]
  53. Yu S., Opriessnig T., Kitikoon P., Nilubol D., Halbur P. G., Thacker E. 2007; Porcine circovirus type 2 (PCV2) distribution and replication in tissues and immune cells in early infected pigs. Vet Immunol Immunopathol 115:261–272 [CrossRef]
    [Google Scholar]
  54. Zakhartchouk A. N., Liu Q., Petric M., Babiuk L. A. 2005; Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines. Vaccine 23:4385–4391 [CrossRef]
    [Google Scholar]
  55. Zhou J. Y., Shang S. B., Gong H., Chen Q. X., Wu J. X., Shen H. G., Chen T. F., Guo J. Q. 2005a; In vitro expression, monoclonal antibody and bioactivity for capsid protein of porcine circovirus type II without nuclear localization signal. J Biotechnol 118:201–211 [CrossRef]
    [Google Scholar]
  56. Zhou J. Y., Wang J. Y., Chen J. G., Wu J. X., Gong H., Teng Q. Y., Guo J. Q., Shen H. G. 2005b; Cloning, in vitro expression and bioactivity of duck interleukin-2. Mol Immunol 42:589–598 [CrossRef]
    [Google Scholar]
  57. Zhou J. Y., Chen Q. X., Ye J. X., Shen H. G., Chen T. F., Shang S. B. 2006; Serological investigation and genomic characterization of PCV2 isolates from different geographic regions of Zhejiang province in China. Vet Res Commun 30:205–220 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.2008/000125-0
Loading
/content/journal/jgv/10.1099/vir.0.2008/000125-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error